The Effect of Mitomycin-C on Trabeculectomy in Primary Glaucoma Cases
dc.contributor.author | Caca, Ihsan | |
dc.contributor.author | Unlu, Kaan | |
dc.contributor.author | Sakalar, Yildirim Bayezit | |
dc.contributor.author | Ari, Seyhmus | |
dc.date.accessioned | 2024-04-24T17:47:27Z | |
dc.date.available | 2024-04-24T17:47:27Z | |
dc.date.issued | 2005 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Purpose: The aim of this study was to determine the effect of mitomycin-C (MMC) treatment on the accomplishments and complications of trabeculectomy. Materials and Methods: 75 eyes of 59 (group 1) primary glaucoma cases that were treated with trabeculectomy operation together with 0.2 mg/ml 2 minutes intraoperative MMC and 22 eyes of 16 (group 2) glaucoma cases to whom only trabeculectomy operation were evaluated. Results: Cases in the group 1 were followed up 10.87 +/- 2.88 months meanly and cases in the group 2 were followed up 9.55 +/- 2.56 months meanly. In all of group 1 and 82% of group 2, intraocular pressure was found postoperatively to . be below 21mmHg. In the postoperative short-term, the most common complications for groupl were anterior chamber shallowness in 22 cases (30%), temporary ocular hypotonia in 21 cases (28%), conjunctival leakage in 8 cases (11 %), while for group 2 the most complications were intraocular pressure rise in 5 cases (23%), anterior chamber shallowness in 3 cases (14%) and temporary ocularhypotonia in 2 cases (9%). The complications appeared in the postoperative long-term for group 1 were endophthalmitis in 1 case (1.3%) and cataract formation in 7 cases (9%) whereas for group 2 were steady high intraocular pressure in 4 cases (18%) and cataract formation in 2 cases (9%). Conclusion: 0.2 mg/ml 2 minutes intraoperative MMC increases considerably the success rate of trabeculectomy in primary glaucoma cases. Nevertheless, postoperative short-term complications should be followed at close range and treated. | en_US |
dc.identifier.endpage | 238 | en_US |
dc.identifier.issn | 1300-0659 | |
dc.identifier.issn | 2147-2661 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | 232 | en_US |
dc.identifier.uri | https://hdl.handle.net/11468/22493 | |
dc.identifier.volume | 35 | en_US |
dc.identifier.wos | WOS:000217201700009 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.language.iso | tr | en_US |
dc.publisher | Turkish Ophthalmological Soc | en_US |
dc.relation.ispartof | Turk Oftalmoloji Dergisi-Turkish Journal of Ophthalmology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Primary Glaucoma | en_US |
dc.subject | Mitomycin-C | en_US |
dc.subject | Trabeculectomy | en_US |
dc.title | The Effect of Mitomycin-C on Trabeculectomy in Primary Glaucoma Cases | en_US |
dc.title | The Effect of Mitomycin-C on Trabeculectomy in Primary Glaucoma Cases | |
dc.type | Article | en_US |